Lam Research (LRCX)
(Real Time Quote from BATS)
$957.70 USD
+40.59 (4.43%)
Updated Jul 22, 2024 11:12 AM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Income Statements
Fiscal Year end for Lam Research Corporation falls in the month of June .
All items in Millions except EPS data.
6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | |
---|---|---|---|---|---|
Sales | NA | 17,429 | 17,227 | 14,626 | 10,045 |
Cost Of Goods | NA | 9,652 | 9,355 | 7,821 | 5,436 |
Gross Profit | NA | 7,777 | 7,872 | 6,805 | 4,609 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 2,602 | 2,490 | 2,323 | 1,935 |
Income After Depreciation & Amortization | 0 | 5,175 | 5,382 | 4,482 | 2,674 |
Non-Operating Income | NA | -66 | -189 | -111 | -99 |
Interest Expense | NA | 0 | 0 | 0 | 0 |
Pretax Income | NA | 5,109 | 5,193 | 4,371 | 2,575 |
Income Taxes | NA | 598 | 588 | 462 | 323 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | 4,511 | 4,605 | 3,908 | 2,252 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
Net Income (GAAP) | NA | 4,511 | 4,605 | 3,908 | 2,252 |
Depreciation Footnote | 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 5,517 | 5,716 | 4,789 | 2,948 |
Depreciation & Amortization (Cash Flow) | NA | 342 | 334 | 307 | 274 |
Income After Depreciation & Amortization | 0 | 5,175 | 5,382 | 4,482 | 2,674 |
Earnings Per Share Data | 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 |
---|---|---|---|---|---|
Average Shares | NA | 135.83 | 140.63 | 145.32 | 149.09 |
Diluted EPS Before Non-Recurring Items | NA | 34.17 | 33.12 | 27.24 | 15.95 |
Diluted Net EPS (GAAP) | NA | 33.21 | 32.75 | 26.90 | 15.10 |
Fiscal Year end for Lam Research Corporation falls in the month of June .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 3,793.56 | 3,758.26 | 3,482.06 | 3,207.26 |
Cost Of Goods | NA | 1,993.02 | 2,000.80 | 1,827.36 | 1,749.13 |
Gross Profit | NA | 1,800.54 | 1,757.46 | 1,654.70 | 1,458.13 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 743.42 | 700.24 | 631.67 | 603.52 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 1,057.12 | 1,057.22 | 1,023.03 | 854.61 |
Non-Operating Income | NA | 36.07 | 29.84 | 2.60 | 9.01 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | 1,093.19 | 1,087.05 | 1,025.63 | 863.62 |
Income Taxes | NA | 127.36 | 132.79 | 138.23 | 61.08 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 965.83 | 954.27 | 887.40 | 802.54 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 965.83 | 954.27 | 887.40 | 802.54 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 131.52 | 132.22 | 133.17 | 134.39 |
Diluted EPS Before Non-Recurring Items | NA | 7.79 | 7.52 | 6.85 | 5.98 |
Diluted Net EPS (GAAP) | NA | 7.34 | 7.22 | 6.66 | 6.04 |